Natalizumab literature review

Natalizumab literature review


METHODS: Case report and review of the literature.Results 38% of natalizumab treated patients had eosinophilia, which occurred significantly more frequently compared to untreated MS patients (3%, p natalizumab literature review -value.Antezana A(1), Sigal S(2), Herbert J(3), Kister I(3).Author information: (1)Neuromedical Clinic of Central Louisiana, Louisiana, United States.Methods: A systematic literature review (SLR) was conducted to identify published randomised controlled trials in HA and RES RRMS.RESULTS: The case of a 26-year-old Caucasian natalizumab literature review woman natalizumab literature review with RR-MS, who presented with recurrent vaginitis since the initiation of treatment with natalizumab, is reported Natalizumab is an α4-integrin monoclonal antibody used for treatment of relapsing multiple sclerosis (MS).At least and nearly 30 cases of liver failure in natalizumab-treated patients are listed in the post-marketing FDA adverse event reporting system (FAERS) and twelve patients with severe liver injury, including several after the first infusion, have been reported (Lisotti et al.

Writing Custom Comparator

natalizumab literature review natalizumab literature review natalizumab literature review

Leave a Reply

Your email address will not be published. Required fields are marked *